VANECK ETF TRUST - BIOTECH ETF (BBH)

Historical Holders from Q4 2015 to Q3 2025

Symbol
BBH
Type / Class
Equity / BIOTECH ETF
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
653,055
Holdings value
$108,210,357
% of all portfolios
0%
Number of holders
105
Number of buys
26
Number of sells
-42
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of VANECK ETF TRUST - BIOTECH ETF (BBH)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 653,055 $108,210,357 -$15,130,072 $165.68 105
2025 Q2 749,239 $114,979,884 -$11,533,619 $153.28 97
2025 Q1 823,817 $129,308,539 -$20,580,903 $157.33 103
2024 Q4 959,778 $150,670,091 +$12,971,754 $156.97 116
2024 Q3 856,187 $151,646,117 +$1,691,211 $177.39 114
2024 Q2 848,206 $142,824,724 -$9,633,264 $168.41 115
2024 Q1 905,258 $150,577,291 -$5,847,660 $166.33 112
2023 Q4 959,553 $158,633,631 -$4,040,687 $165.31 116
2023 Q3 973,433 $151,595,523 -$16,056,546 $155.73 111
2023 Q2 1,095,921 $170,839,038 +$21,684,376 $156.05 111
2023 Q1 948,657 $153,930,369 +$7,096,388 $162.09 114
2022 Q4 913,684 $145,962,879 +$17,659,057 $159.74 117
2022 Q3 800,025 $112,644,749 -$3,045,181 $140.78 103
2022 Q2 844,818 $123,167,423 -$809,207 $145.79 106
2022 Q1 843,284 $136,730,953 -$10,729,817 $162.13 113
2021 Q4 902,043 $170,582,250 +$17,767,194 $189.33 123
2021 Q3 804,881 $162,715,551 +$3,193,694 $202.13 118
2021 Q2 783,412 $157,963,396 +$1,508,438 $201.66 112
2021 Q1 776,297 $136,185,051 +$9,292,228 $175.44 105
2020 Q4 723,878 $122,821,651 -$11,348,803 $169.68 110
2020 Q3 811,222 $131,452,614 -$2,603,942 $162.08 102
2020 Q2 793,884 $129,353,080 +$36,441,945 $162.93 102
2020 Q1 566,339 $72,490,373 +$11,117,093 $128.00 82
2019 Q4 482,916 $67,322,949 -$6,609,358 $139.42 85
2019 Q3 539,341 $63,660,209 -$2,590,338 $117.98 77
2019 Q2 556,456 $71,747,073 -$2,511,142 $128.94 79
2019 Q1 580,281 $74,541,968 -$3,777,202 $128.49 87
2018 Q4 607,324 $67,362,554 -$4,554,735 $110.71 82
2018 Q3 639,503 $86,947,170 +$11,080,521 $136.02 82
2018 Q2 564,036 $67,830,955 -$7,377,489 $120.00 83
2018 Q1 626,209 $75,362,789 -$101,038,617 $120.32 81
2017 Q4 1,438,161 $179,227,773 -$52,448,806 $124.60 80
2017 Q3 1,853,785 $248,652,790 +$13,013,731 $134.12 78
2017 Q2 1,758,327 $220,890,303 -$1,567,342 $125.63 81
2017 Q1 1,776,367 $211,457,097 +$24,851,966 $119.05 77
2016 Q4 1,582,627 $170,348,340 +$20,109,839 $107.57 84
2016 Q3 1,398,623 $161,120,204 +$67,555,899 $115.20 77
2016 Q2 799,399 $82,328,378 +$76,813,156 $102.34 75
2016 Q1 35,334 $3,662,000 +$3,487,000 $103.64 5
2015 Q4 1,691 $214,000 +$213,000 $105.10 2